Advanced glycation and inflammatory phenomena in renal transplantation
PhD ceremony: Mr. S. Gross, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen
Thesis: Advanced glycation and inflammatory phenomena in renal transplantation
Promotor(s): prof. R.O.B. Gans, prof. S.J.L. Bakker
Faculty: Medical Sciences
The function of a kidney is to remove toxic substances from the blood en to excrete them with the urine. Since a transplanted kidney does not work 100% efficient, toxic substances such as AGEs can accumulate on renal transplant recipients. These AGEs (abbreviation for Advanced Glycation End-products) are present in everyday meals and develop spontaneous in the body due to e.g. high blood sugar (diabetes). It is thought that AGEs have bad effects by connecting proteins or causing chronic inflammation. This can lead to damaging of blood vessels, which enhances the chance to die. The results of this thesis showed that indeed the presence of AGEs were associated with a higher risk for dieing, while the presence of S100B was not. This suggests that the presence of AGEs is an important risk factor for death after renal transplantation and that AGEs cause damage to blood vessel by connecting proteins rather than by causing chronic inflammation.
| Last modified: | 13 March 2020 01.15 a.m. |
More news
-
22 January 2021
Individueel beweegadvies maakt bewegen als medicijn mogelijk
Er is een sterke behoefte in de ziekenhuiszorg om bewegen als medicijn voor te schrijven, maar er zijn ook veel barrières in de uitvoering ervan. Dit blijkt uit onderzoek van het UMCG en Amsterdam UMC. Daarom zijn nu verschillende materialen en...
-
18 January 2021
Researchers should pay more attention to children’s needs and wishes
Researchers who conduct medical research into children should pay more attention to their needs and wishes. This would improve the quality of the research and ultimately benefit children’s healthcare. These are the conclusions of Malou Luchtenberg,...
-
07 January 2021
Over €3 million for research into increased vaccine coverage for minorities
The UMCG will lead an international study aimed at increasing vaccine coverage for minority groups, including those with a minority ethnic background, in Europe. €3.3 million has been made available for the project as part of the EU programme...